Charles River Laboratories Soars Past 52‑Week High on Q2 Earnings Beat and Strong 2026 Outlook
Charles River Laboratories jumps to a 52‑week high after beating Q2 earnings expectations, with a record book‑to‑bill ratio and upbeat 2026 revenue outlook.
3 minutes to read